Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2112 | 5117 | 34.7 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
429 | 3 | SPHINGOSINE 1 PHOSPHATE//CERAMIDE//SPHINGOLIPIDS | 27734 |
2112 | 2 | PLATELET ACTIVATING FACTOR//LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2//PAF | 5117 |
278 | 1 | PLATELET ACTIVATING FACTOR//PAF//PAF ANTAGONIST | 3744 |
12861 | 1 | LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2//LP PLA2//PLATELET ACTIVATING FACTOR ACETYLHYDROLASE | 876 |
19613 | 1 | EARLY PREGNANCY FACTOR//ROSETTE INHIBITION TEST//PREIMPLANTATION FACTOR | 497 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PLATELET ACTIVATING FACTOR | authKW | 1526668 | 12% | 41% | 632 |
2 | LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 | authKW | 650016 | 3% | 74% | 148 |
3 | PAF | authKW | 589098 | 4% | 44% | 226 |
4 | PAF ANTAGONIST | authKW | 371207 | 2% | 68% | 92 |
5 | LP PLA2 | authKW | 347041 | 2% | 73% | 80 |
6 | PLATELET ACTIVATING FACTOR PAF | authKW | 314576 | 2% | 58% | 91 |
7 | PAF ACETYLHYDROLASE | authKW | 278405 | 1% | 68% | 69 |
8 | JOURNAL OF LIPID MEDIATORS | journal | 240786 | 2% | 38% | 105 |
9 | PLATELET ACTIVATING FACTOR ACETYLHYDROLASE | authKW | 215364 | 1% | 56% | 65 |
10 | PAF RECEPTOR | authKW | 188429 | 1% | 64% | 49 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 4452 | 19% | 0% | 981 |
2 | Biochemistry & Molecular Biology | 3996 | 26% | 0% | 1344 |
3 | Reproductive Biology | 3440 | 5% | 0% | 276 |
4 | Immunology | 2025 | 11% | 0% | 573 |
5 | Peripheral Vascular Diseases | 1765 | 6% | 0% | 315 |
6 | Biophysics | 1320 | 7% | 0% | 351 |
7 | Cell Biology | 1102 | 9% | 0% | 484 |
8 | Allergy | 964 | 2% | 0% | 114 |
9 | Hematology | 662 | 4% | 0% | 219 |
10 | Medicine, Research & Experimental | 498 | 5% | 0% | 249 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SCI NUTR DIETET | 57722 | 0% | 44% | 22 |
2 | DEV MED BIOTECHNOL | 35793 | 0% | 100% | 6 |
3 | HB WELLS PEDIAT | 25012 | 0% | 22% | 19 |
4 | NORA ECCLES HARRISON CARDIOVASC TRAINING INS | 18639 | 0% | 63% | 5 |
5 | REPROD PRIMATOL | 17897 | 0% | 100% | 3 |
6 | BASIC PL UNIT | 13421 | 0% | 75% | 3 |
7 | YALE WOMEN CHILDRENS BLOOD DISORDERS | 12304 | 0% | 26% | 8 |
8 | BAYLOR LIPID ATHEROSCLEROSIS CLIN | 11931 | 0% | 100% | 2 |
9 | BIOCHEM MOL BIOL MEDBUNKYO KU | 11931 | 0% | 100% | 2 |
10 | CATTEDRA NEFROL IMMUNOPATOL | 11931 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF LIPID MEDIATORS | 240786 | 2% | 38% | 105 |
2 | JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING | 178219 | 2% | 33% | 91 |
3 | AGENTS AND ACTIONS | 10896 | 2% | 2% | 77 |
4 | LIPIDS | 10178 | 2% | 2% | 101 |
5 | PROSTAGLANDINS | 9662 | 1% | 3% | 49 |
6 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 4704 | 1% | 2% | 38 |
7 | PHARMACOLOGICAL RESEARCH COMMUNICATIONS | 4371 | 1% | 3% | 26 |
8 | BRITISH JOURNAL OF PHARMACOLOGY | 3823 | 2% | 1% | 109 |
9 | INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY | 3725 | 1% | 2% | 41 |
10 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 3603 | 0% | 3% | 22 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PLATELET ACTIVATING FACTOR | 1526668 | 12% | 41% | 632 | Search PLATELET+ACTIVATING+FACTOR | Search PLATELET+ACTIVATING+FACTOR |
2 | LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 | 650016 | 3% | 74% | 148 | Search LIPOPROTEIN+ASSOCIATED+PHOSPHOLIPASE+A2 | Search LIPOPROTEIN+ASSOCIATED+PHOSPHOLIPASE+A2 |
3 | PAF | 589098 | 4% | 44% | 226 | Search PAF | Search PAF |
4 | PAF ANTAGONIST | 371207 | 2% | 68% | 92 | Search PAF+ANTAGONIST | Search PAF+ANTAGONIST |
5 | LP PLA2 | 347041 | 2% | 73% | 80 | Search LP+PLA2 | Search LP+PLA2 |
6 | PLATELET ACTIVATING FACTOR PAF | 314576 | 2% | 58% | 91 | Search PLATELET+ACTIVATING+FACTOR+PAF | Search PLATELET+ACTIVATING+FACTOR+PAF |
7 | PAF ACETYLHYDROLASE | 278405 | 1% | 68% | 69 | Search PAF+ACETYLHYDROLASE | Search PAF+ACETYLHYDROLASE |
8 | PLATELET ACTIVATING FACTOR ACETYLHYDROLASE | 215364 | 1% | 56% | 65 | Search PLATELET+ACTIVATING+FACTOR+ACETYLHYDROLASE | Search PLATELET+ACTIVATING+FACTOR+ACETYLHYDROLASE |
9 | PAF RECEPTOR | 188429 | 1% | 64% | 49 | Search PAF+RECEPTOR | Search PAF+RECEPTOR |
10 | ACETYLHYDROLASE | 173746 | 1% | 79% | 37 | Search ACETYLHYDROLASE | Search ACETYLHYDROLASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MONTRUCCHIO, G , ALLOATTI, G , CAMUSSI, G , (2000) ROLE OF PLATELET-ACTIVATING FACTOR IN CARDIOVASCULAR PATHOPHYSIOLOGY.PHYSIOLOGICAL REVIEWS. VOL. 80. ISSUE 4. P. 1669 -1699 | 316 | 75% | 226 |
2 | BRAQUET, P , TOUQUI, L , SHEN, TY , VARGAFTIG, BB , (1987) PERSPECTIVES IN PLATELET-ACTIVATING-FACTOR RESEARCH.PHARMACOLOGICAL REVIEWS. VOL. 39. ISSUE 2. P. 97-145 | 256 | 77% | 1416 |
3 | OSTERMANN, G , KERTSCHER, HP , HOFMANN, B , (1990) PLATELET-ACTIVATING FACTOR - A BIOLOGICALLY-ACTIVE PHOSPHOLIPID.PHARMAZIE. VOL. 45. ISSUE 7. P. 465-487 | 381 | 85% | 2 |
4 | ISHII, S , SHIMIZU, T , (2000) PLATELET-ACTIVATING FACTOR (PAF) RECEPTOR AND GENETICALLY ENGINEERED PAF RECEPTOR MUTANT MICE.PROGRESS IN LIPID RESEARCH. VOL. 39. ISSUE 1. P. 41 -82 | 211 | 61% | 213 |
5 | KOLTAI, M , HOSFORD, D , GUINOT, P , ESANU, A , BRAQUET, P , (1991) PAF A REVIEW OF ITS EFFECTS, ANTAGONISTS AND POSSIBLE FUTURE CLINICAL IMPLICATIONS .2..DRUGS. VOL. 42. ISSUE 2. P. 174 -204 | 244 | 77% | 103 |
6 | MIKLISHANSKAYA, SV , LYAKISHEV, AA , KUKHARCHUK, VV , (2013) CLINICAL ROLE OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2.KARDIOLOGIYA. VOL. 53. ISSUE 3. P. 59 -70 | 116 | 89% | 1 |
7 | SNYDER, F , (1995) PLATELET-ACTIVATING-FACTOR AND ITS ANALOGS - METABOLIC PATHWAYS AND RELATED INTRACELLULAR PROCESSES.BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM. VOL. 1254. ISSUE 3. P. 231 -249 | 184 | 75% | 151 |
8 | STAFFORINI, DM , ROSENSON, RS , (2012) MODULATION OF OXIDATIVE STRESS, INFLAMMATION, AND ATHEROSCLEROSIS BY LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2).JOURNAL OF LIPID RESEARCH. VOL. 53. ISSUE 9. P. 1767 -1782 | 112 | 67% | 50 |
9 | HANDLEY, DA , (1990) PRECLINICAL AND CLINICAL-PHARMACOLOGY OF PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONISTS.MEDICINAL RESEARCH REVIEWS. VOL. 10. ISSUE 3. P. 351 -370 | 188 | 96% | 13 |
10 | TELLIS, CC , TSELEPIS, AD , (2014) PATHOPHYSIOLOGICAL ROLE AND CLINICAL SIGNIFICANCE OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2) (LP-PLA(2)) BOUND TO LDL AND HDL.CURRENT PHARMACEUTICAL DESIGN. VOL. 20. ISSUE 40. P. 6256 -6269 | 102 | 77% | 6 |
Classes with closest relation at Level 2 |